HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Sides With Gillette Over Energizer In Case Examining Schick Razor Ad

This article was originally published in The Rose Sheet

Executive Summary

The National Advertising Division concludes that by claiming the Schick Intuition Plus razor "lathers, shaves and moisturizes in one easy step," Energizer Personal Care is implying a long-term post-shave benefit comparable to that awarded by leave-on moisturizer, which is not supported by the company's evidence

You may also be interested in...



Splitting Hairs: NAD Razor Case Disputes Moisturization, “Less Dryness”

P&G’s Gillette brand holds that moisturization claims in advertising for its Venus & Olay women’s razor are tied to clinical testing showing comparatively “less dryness” in users’ legs over time. NAD sides with challenger Energizer/Schick, asserting that there is a difference between moisturization and dryness prevention.

Gillette, Energizer Cross Razors Again With NAD Challenges

Razor competitors Gillette and Energizer have each turned to the National Advertising Division to challenge claims made in the other's marketing, and both have been advised to modify advertising for their men's razors.

Gillette, Energizer Cross Razors Again With NAD Challenges

Razor competitors Gillette and Energizer have each turned to the National Advertising Division to challenge claims made in the other's marketing, and both have been advised to modify advertising for their men's razors.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017304

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel